title: Duloxetine for neuropathic pain based on recent clinical trials.
abstract: The treatment of neuropathic pain with antidepressants has a long history. Early studies were contradictory and were limited by small numbers of patients. When evaluated meta-analytically, these studies indicated that antidepressants do have efficacy for neuropathic pain. However, none of the antidepressants used in these studies have gained approval by the US Food and Drug Administration (FDA) for this indication, and were generally associated with a high side-effect burden. Recently, duloxetine, a dual-action reuptake inhibitor, has demonstrated significant efficacy in the management of diabetic peripheral neuropathic pain in three double-blind, placebo-controlled trials and was approved by the FDA for this indication. These studies are discussed in this article.
authors.affiliation: Department of Psychiatry, Miller School of Medicine, University of Miami, 1400 N.W. 10th Avenue, Suite 301, Miami Beach, FL 33136, USA. d.fishbain@miami.edu
authors.forename: David
authors.initials: D
authors.lastname: Fishbain
authors.forename: Kim
authors.initials: K
authors.lastname: Berman
authors.forename: Daniel K
authors.initials: DK
authors.lastname: Kajdasz
mesh_terms: D000928:Antidepressive Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D000068736:Duloxetine Hydrochloride; D006801:Humans; D009437:Neuralgia / Q000188:drug therapy*; D013876:Thiophenes / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000928:Antidepressive Agents; D013876:Thiophenes; D000068736:Duloxetine Hydrochloride
references.citation: Pain. 1992 May;49(2):205-219
references.pmid: 1535121
references.citation: Pain Med. 2005 Sep-Oct;6(5):346-56
references.pmid: 16266355
references.citation: Psychosomatics. 2000 Mar-Apr;41(2):104-13
references.pmid: 10749947
references.citation: Arch Intern Med. 1999 Sep 13;159(16):1931-7
references.pmid: 10493324
references.citation: Neurology. 2003 Apr 22;60(8):1284-9
references.pmid: 12707430
references.citation: Ann Med. 2000 Jul;32(5):305-16
references.pmid: 10949061
references.citation: J Clin Psychiatry. 2002 Mar;63(3):225-31
references.pmid: 11926722
references.citation: J Clin Psychiatry. 2004 Apr;65(4):521-30
references.pmid: 15119915
references.citation: Pain. 1986 Aug;26(2):181-197
references.pmid: 3763232
references.citation: Brain Res. 1993 Jul 9;616(1-2):200-10
references.pmid: 7689410
references.citation: J Clin Psychopharmacol. 2004 Aug;24(4):389-99
references.pmid: 15232330
references.citation: J Fam Pract. 1999 Dec;48(12):980-90
references.pmid: 10628579
references.citation: Pain. 1996 Dec;68(2-3):217-27
references.pmid: 9121808
references.citation: Clin J Pain. 1997 Dec;13(4):313-23
references.pmid: 9430812
references.citation: Pharmacopsychiatry. 1993 Nov;26(6):221-34
references.pmid: 8127926
references.citation: J Psychiatr Res. 2002 Nov-Dec;36(6):383-90
references.pmid: 12393307
references.citation: Pain. 2005 Jul;116(1-2):109-18
references.pmid: 15927394
references.citation: Diabetes Care. 2004 Jun;27(6):1458-86
references.pmid: 15161806
references.citation: Annu Rev Neurosci. 1984;7:309-38
references.pmid: 6143527
references.citation: Clin J Pain. 2000 Mar;16(1):73-85
references.pmid: 10741821
references.citation: Spine (Phila Pa 1976). 2003 Nov 15;28(22):2540-5
references.pmid: 14624092
references.citation: Arch Intern Med. 2002 Jan 14;162(1):19-24
references.pmid: 11784215
references.citation: Psychosom Med. 1998 Jul-Aug;60(4):503-9
references.pmid: 9710298
references.citation: J Clin Psychiatry. 2002 Apr;63(4):308-15
references.pmid: 12000204
references.citation: Pain. 2004 Aug;110(3):697-706
references.pmid: 15288411
references.citation: JAMA. 1998 Dec 2;280(21):1831-6
references.pmid: 9846777